Bonelli J
Int J Clin Pharmacol Biopharm. 1978 Jul;16(7):313-9.
The hemodynamic effect of a beta-receptor blockade with mepindolol--a noncardioselective beta-receptor blocker--was studied in 6 male test subjects age 25 to 30 years with an increasing dose of isoproterenol. The cardiac output per min, the heart rate and the stroke volume, the wet blood pressure and the contractility parameters dp/dt max in the right and left ventricles were measured as part of the study. It was found that a dissociated right shift of the dose-effect curves occurred for the stroke volume, contractility parameters and heart rate. The following major conclusions can be made from an exact analysis of this result: 1. Evidence was produced that a distinction must be made in man with respect to the so-called beta1-receptors between those which mediate a specific effect on the heart rate and those which mediate a primarily positively inotropic effect. 2. There are apparently some beta-receptor blockers which inhibit the frequency receptors primarily and the inotropic receptors to a lesser extent. 3. Through their beta 2-effect, noncardioselective beta-receptor blockers can partly compensate for their negatively inotropic effect on the heart by maintaining the Frank Starling mechanism.
在6名年龄为25至30岁的男性受试者中,研究了使用美吡吲哚(一种非心脏选择性β受体阻滞剂)进行β受体阻滞时,随着异丙肾上腺素剂量增加所产生的血流动力学效应。作为研究的一部分,测量了每分钟心输出量、心率和每搏输出量、湿血压以及左右心室的收缩性参数dp/dt max。结果发现,每搏输出量、收缩性参数和心率的剂量-效应曲线出现了解离性右移。对这一结果进行精确分析可得出以下主要结论:1. 有证据表明,在人体中,介导对心率特定效应的所谓β1受体与主要介导正性肌力效应的β1受体之间必须加以区分。2. 显然存在一些β受体阻滞剂,它们主要抑制频率受体,而对肌力受体的抑制作用较小。3. 通过其β2效应,非心脏选择性β受体阻滞剂可通过维持Frank Starling机制部分补偿其对心脏的负性肌力作用。